Treatment of thalassemia-induced osteoporosis with intermittent pamidronate infusions: Two-year follow up

Turkish Journal of Hematology

Volumn 25, Issue 2, 2008, Pages 79-82

  Patiroǧlu, Türkan ^a   Altuner Torun, Yasemin ^a   Kula, Mustafa ^a   Karakükçü, Musa ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Osteoporosis; Pamidronate; Thalassemia

Indexed keywords

CALCIUM; DEFEROXAMINE; PAMIDRONIC ACID; VITAMIN D;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; CLINICAL TRIAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; HUMAN; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; SCHOOL CHILD; THALASSEMIA;

EID: 48649110235     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med 2005;353:1135-46.
2. Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol 2004; 127:127-39.
3. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B. High incidence of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab 1998; 11:975-7.
4. Lala R, Chiabotto P, Di Stefano M, Isala GC, Garofalo F, Piga A. Bone density and metabolism in thalasseemia. J Pediatr Endocrinol Metab 1998;11:785-90.
5. Perrotta S, Cappellini MD, Bertoldo F, Servedio V, Iolascon G, D'Agruma L, Gasparini P, Sicillani MC, Iolascon A. Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. Br J Haematol 2000;111:461-6.
6. Lasoo A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N. Effects of hormonal replacement thempy on bone metabolism in young adults with beta-thalassemia major. Ostoporos Int 2001;12:570-5.
7. De Virgillis S, Congia M, Frau F, Argiolu F, Diana G, Cucca F, Varsi A, Sanna G, Podda G, Fodde M. Deferoxamine-induced growth retardation in patents with thalassemia major. J Pedlatr 1988;113:661-9.
8. Roth C, Pekrun A, Bartz M, Jarry H, Eber S, Lakomek M, Schroter W. Short stature and failuna of pubertal development in thalassaemia mejor: evidence for hypothalemic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion, Eur J Pediatr 1997;156:777-83.
9. Soliman AT, El Banna N, Abdel Fattah M, ElZalabani MM, Ansari BM. Bone mineral density in prepubertal children with beta-thalassemja: correlation with growth and hormonal data. Metabolism 1998;47:541-8.
10. Shamshirsaz AA, Bekheimia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, Hashemi R, Shamshirsaz AA, Aghakhani S, Homayoun H, Larijani B. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003;3:4.
11. Fleisch H. Bisphosphonates in osteoporosis. Eur Spine J 2003;12:142-6.
12. Morabito N, Lasco A, Gaudio A, Crisafulli A, Di Pietro C, Meo A, Frisina N. Bisphosphonates in the treatment of thalassernia-induced osteoporosis. Osteoporos; Int 2002;13:644-9.
13. Shaw NJ, Boivin CM, Crabtree NJ. Intravenous pamidronate in juvenile osteoporosis. Arch Dis Child 2000;83:143-5.
14. Allgrove J. Use of bisphosphonates in children and adolescents. J Pediatr Endocrinol Metab 2002;15:921-8.
15. Vichinsky EP. The morbidity of bone disease in thalassemia. Ann N Y Acad Sci 1998;850:344-8.
16. Domrongkitchaipom S, Sirikulchayanonta V, Angchaisuksiri P, Stitchantrakul W, Kanokkantapong C. Rajatanavin R. Abnormalities in bone mineral density and bone histology in thalassemia. J Bone Miner Res 2003; 18:1682-8.
17. Voskaridou E, Kyrtsonis MC, Terpos E, Skordili M. Theodoropoulos I, Bergele A., Diamanti E, Kalovidouris A, Loutradi A, Loukopoulos D. Bone resorption is increased in young adults with thalassaemia major. Br J Haematol 2001; 112:36-41.
18. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone minerol metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol 2000; 111:902-7.
19. Molyvda-Athanasopoulou E, Sioundas A, Karatzas N, Aggellaki M, Pazaitou K, Vainas I. Bone mineral density of patients with thalassemia major: four-year follow-up. Calcif Tissue Int 1999;64:481-4.
20. Bielinski BK, Daryshire P, Mathers L, Boivin CM, Shaw NJ. Bone density in the Asian thalassaemic population: a cross-sectional review. Acta Paediatr 2001;90:1262-6.
21. Vazigi A, Maalouf G, Inati-Khoriati A, Tamim H, Saab Bone mineral density in beta - thalassemic Lebanese children. J Musculoskelet Neuronal Interact 2002;2:463-8.
22. Voskaridou E, Terpos E, Spina G, Palermos J, Rahemtulla A, Loutradi A, Loukopoulos D. Pamidronate is ap effective treatment for osteoporosis in patients with beta-thalassaemia. Br J Haematol 2003; 123:730-7.
23. Steelman J, Zeitler P. Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J Pediatr 2003; 142:417-23.
24. Gonzalez E, Pavia C, Ros J, Villaronga M, Valls C, Escola J. Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab 2061;14:529-33.
25. Hodsman AB, Hanley DA, Josse R. Do Bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. CMAJ 2002;166:1426-30.
26. Wonke B. Clinical management of beta-thalassemia major. Semin Hematol 2001;38:350-9.